萨科佩尼亚对治疗勃起功能障碍的影响
Aykut Başer1, Çağrı Doğan2, Okan Alkiş3
1Department of Urology, Bandırma Onyedi Eylül University Faculty of Medicine, 10200 Balıkesir, Turkey.
Archivos espanoles de urologia
|October 20, 2025
概括
肉,一种肌肉损失的情况,可能会阻碍有效的勃起功能障碍 (ED) 治疗. 怀疑患有肉类的老年男性对治疗ED的代酶5型抑制剂 (PDE5i) 反应较差.
科学领域:
- 老年学是一门学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 肌肉生理学 肌肉生理学
背景情况:
- 勃起功能障碍 (ED) 和麻症共享与年龄相关的危险因素.
- 调查肉症对ED治疗的影响对于了解治疗结果至关重要.
研究的目的:
- 为了评估萨科佩尼亚对ED治疗有效性的影响.
- 为了确定萨科佩尼亚是否会影响使用固酶5型抑制剂 (PDE5i) 的患者的治疗反应.
主要方法:
- 一项前性观察性研究,涉及137名在6个中心接受ED治疗的患者.
- 使用SARC-F问卷,30秒椅子站测试和4米步行测试来评估萨科佩尼亚.
- 使用国际勃起功能指数 (IIEF) 问卷和PDE5i使用情况来测量ED严重程度和治疗反应.
主要成果:
- 15.33%的患者表现出怀疑的肉症,并且年龄较大,基线IIEF得分较低.
- 在PDE5i治疗 (11.64至17.28) 后,没有肉症的患者显示出显著的IIEF评分改善.
- 怀疑患有皮症的患者在治疗后没有显著的IIEF评分增加 (8.76至9.81).
结论:
- 肉可能是导致勃起功能障碍治疗反应不佳的因素.
- 患有皮症的老年患者可能会对PDE5i等标准ED疗法产生抗性.
- 识别肉类可能有助于个性化ED治疗策略,以获得更好的结果.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
554
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
554
Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
438
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
438
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K


